FDA Approves Sanofi Pill for Neurological Form of Gaucher Disease
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
Federal regulators on Nov. 18 cleared Infilbray, a daily pill from Sanofi also called venglustat…
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
5 confirmed facts, 1 open question and 2 sources behind this story.